S100P and intrahepatic cholangiocarcinoma: In our data, SPP1 was strongly expressed in intrahepatic cholangiocarcinoma and S100P had predominant expression in distal bile duct and gallbladder adenocarcinoma (Figure S9A), but there were also many cells without either SPP1 and S100P expression.